Koers Callitas Health Inc. Canadian Securities Exchange
Aandelen
LILY
CA13125C1068
Biotechnologie & Medisch Onderzoek
Omzet 2018 | 0,75 1,03 0,69 | Omzet 2019 | 0,71 0,97 0,65 | Marktkapitalisatie | 3,53 mln. 4,82 mln. 3,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -5 mln. -6,83 mln. -4,61 mln. | Nettowinst (verlies) 2019 | -1 mln. -1,37 mln. -923K | EV/omzet 2018 | 4.852.616 x |
Nettoschuld 2018 | 319K 436K 294K | Nettoschuld 2019 | 848K 1,16 mln. 782K | EV/omzet 2019 | 6.168.166 x |
K/w-verhouding 2018 |
-0,6
x | K/w-verhouding 2019 |
-1,97
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 72,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+57,55% | 55,07 mld. | |
-1,59% | 41,79 mld. | |
+44,30% | 40,22 mld. | |
-7,59% | 28,17 mld. | |
+12,35% | 26,28 mld. | |
-21,12% | 18,93 mld. | |
+7,10% | 13,03 mld. | |
+28,80% | 12,26 mld. | |
+26,32% | 12,21 mld. |